Holen Sie sich die Stockscreener-App
6.99
0.14%
-0.010
Handel nachbörslich:
6.86
-0.13
-1.86%
Schlusskurs vom Vortag:
$7.00
Offen:
$6.95
24-Stunden-Volumen:
154.85K
Relative Volume:
0.74
Marktkapitalisierung:
$258.81M
Einnahmen:
$128.45M
Nettoeinkommen (Verlust:
$6.54M
KGV:
139.80
EPS:
0.05
Netto-Cashflow:
$-8.79M
1W Leistung:
-5.92%
1M Leistung:
-12.19%
6M Leistung:
+17.68%
1J Leistung:
+15.92%
1-Tages-Spanne:
$6.79
$7.03
1-Wochen-Bereich:
$6.79
$7.61
52-Wochen-Spanne:
$3.6793
$8.85
Lifecore Biomedical Inc Stock (LFCR) Company Profile
Firmenname
Lifecore Biomedical Inc
Sektor
Telefon
(952) 368-4300
Adresse
3515 LYMAN BOULEVARD, CHASKA
Vergleichen Sie LFCR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LFCR
Lifecore Biomedical Inc
|
6.99 | 259.18M | 128.45M | 6.54M | -8.79M | 0.05 |
|
ZTS
Zoetis Inc
|
147.38 | 64.91B | 9.29B | 2.52B | 2.28B | 5.57 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.16 | 43.33B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
HLN
Haleon Plc Adr
|
9.66 | 42.36B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
15.38 | 17.72B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
294.28 | 12.42B | 2.99B | 1.21B | 1.13B | 25.06 |
Lifecore Biomedical Inc Stock (LFCR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-05-21 | Eingeleitet | William Blair | Outperform |
| 2024-09-05 | Eingeleitet | Craig Hallum | Buy |
| 2024-08-28 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2023-03-20 | Herabstufung | Stephens | Overweight → Equal-Weight |
Lifecore Biomedical Inc Aktie (LFCR) Neueste Nachrichten
Short interest data insights for Lifecore Biomedical Inc.Predicted Market Direction Based on Momentum - Newser
Lifecore Biomedical Inc. Stock Chart Analysis: Bullish or Bearish Pattern FormingLow Risk Stock Selection Strategy Guide - Newser
Is Lifecore Biomedical Inc. stock a good hedge against inflationScalable Strategy with Chart Confirmation - Newser
Published on: 2025-07-31 22:42:45 - Newser
Why is Lifecore Biomedical Inc. stock attracting strong analyst attentionMarket Forecast Target Finder For 2025 - jammulinksnews.com
Signal strength of Lifecore Biomedical Inc. stock in tech scannersCapital Growth Summary Over Five Years - Newser
Lifecore Biomedical to Report Fourth Quarter and Fiscal Year 2025 Financial Results on August 7, 2025 - GlobeNewswire
Lifecore Biomedical Q4 Earnings Call: How to Join the August 7 Investor Presentation - Stock Titan
Momentum divergence signals in Lifecore Biomedical Inc. chartEarnings Impact and Stock Reaction Analysis - Newser
Moving Average Trends for Lifecore Biomedical Inc. Stock: What They IndicateAI Generated Momentum Stock Forecast Guide - Newser
How Lifecore Biomedical Inc. stock performs during market volatilitySmart Chart Forecasting with AI Algorithms - Newser
Ranking Lifecore Biomedical Inc. among high performing stocks via toolsStock Market Trend and Pattern Analysis - Newser
Why Lifecore Biomedical Inc. stock attracts strong analyst attentionFundamental + Technical Combined Watchlist - Newser
What are analysts’ price targets for Lifecore Biomedical Inc. in the next 12 monthsLow Risk Alerts Backed By Experts - jammulinksnews.com
Is Lifecore Biomedical Inc. Stock a Smart Buy in 2025 Investment Analysis InsideTriple Digit Gain Opportunity Watchlist - Newser
Will Lifecore Biomedical Inc. stock go up soonDaily Swing Candidate Analysis with Chart Patterns - Newser
How many analysts rate Lifecore Biomedical Inc. as a “Buy”Consistent triple-digit returns - jammulinksnews.com
Signal strength of Lifecore Biomedical Inc. stock in tech scanners Investment Timing Strategy with Market Filters - Newser
What makes Lifecore Biomedical Inc. stock price move sharplyMarket-leading growth rates - jammulinksnews.com
What catalysts could drive Lifecore Biomedical Inc. stock higher in 2025Get ahead with breakthrough trading ideas - jammulinksnews.com
When is Lifecore Biomedical Inc. stock expected to show significant growthDiscover high-impact investment opportunities - jammulinksnews.com
How Resilient Is Lifecore Biomedical Inc. Stock During Economic DownturnsFree Stock Selection - Newser
Is Lifecore Biomedical Inc. a good long term investmentFree Popular Stock Recommendations - PrintWeekIndia
What analysts say about Lifecore Biomedical Inc. stockHigh-impact stock picks - PrintWeekIndia
What drives Lifecore Biomedical Inc. stock priceBreakthrough profits - Autocar Professional
Laughing Water Capital’s View on Lifecore Biomedical (LFCR) - Insider Monkey
Laughing Water Capital’s View on Lifecore Biomedical Inc. (LFCR) - Insider Monkey
Lifecore Biomedical Inc. Stock Analysis and ForecastFree Trading Psychology Coaching - Autocar Professional
Finanzdaten der Lifecore Biomedical Inc-Aktie (LFCR)
Umsatz
Nettogewinn
Free Cashflow
ENV
Lifecore Biomedical Inc-Aktie (LFCR) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| English Aron R. | 10% Owner |
May 28 '25 |
Sale |
7.12 |
150,419 |
1,071,555 |
264,180 |
| English Aron R. | 10% Owner |
May 23 '25 |
Sale |
6.75 |
96,137 |
649,386 |
1,554,103 |
| English Aron R. | 10% Owner |
May 13 '25 |
Sale |
7.00 |
12,334 |
86,353 |
1,650,240 |
| English Aron R. | 10% Owner |
May 12 '25 |
Sale |
7.03 |
45,698 |
321,426 |
1,662,574 |
| English Aron R. | 10% Owner |
May 08 '25 |
Sale |
7.00 |
5,098 |
35,693 |
1,708,972 |
| English Aron R. | 10% Owner |
May 09 '25 |
Sale |
7.00 |
700 |
4,900 |
1,708,272 |
| English Aron R. | 10% Owner |
May 05 '25 |
Sale |
7.08 |
24,543 |
173,831 |
1,730,618 |
| English Aron R. | 10% Owner |
May 07 '25 |
Sale |
7.01 |
15,847 |
111,099 |
1,714,070 |
| English Aron R. | 10% Owner |
May 06 '25 |
Sale |
7.05 |
701 |
4,940 |
1,729,917 |
| Josephs Paul | Chief Executive Officer |
Jan 08 '25 |
Buy |
5.74 |
17,000 |
97,580 |
559,717 |
0.87%
0.80%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):